CIK 0001069899 · Large accelerated filer
PHIBRO ANIMAL HEALTH CORP
Sign in to watch- Ticker
- PAHC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 131840497
- Phone
- 201-329-7300
- Business address
- GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NJ, 07666
- Former names
- PHILIPP BROTHERS CHEMICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-23 | BENDHEIM JACK President and CEO | Conversion · Class B Common Stock | −58,000 | 20,458,034 | ||
| 2018-03-23 | BFI Co., LLC 10% owner | Conversion | +58,000 | 60,070 | ||
| 2018-03-23 | BFI Co., LLC 10% owner | Sale | −1,900 | $45.12 | $86K | 58,170 |
| 2018-03-23 | BFI Co., LLC 10% owner | Conversion · Class B Common Stock | −58,000 | 20,458,034 | ||
| 2018-03-15 | BFI Co., LLC 10% owner | Sale | −12,000 | $39.98 | $480K | 12,000 |
| 2018-03-15 | BENDHEIM JACK President and CEO | Sale | −12,000 | $39.98 | $480K | 12,000 |
| 2018-03-14 | BFI Co., LLC 10% owner | Sale | −12,000 | $40.12 | $481K | 24,000 |
| 2018-03-14 | BENDHEIM JACK President and CEO | Sale | −12,000 | $40.12 | $481K | 24,000 |
| 2018-03-12 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +13,162 | $11.83 | $156K | 13,162 |
| 2018-03-12 | Bendheim Daniel M Exec. VP, Corporate Strategy | Sale | −13,162 | $40.00 | $526K | 0 |
| 2018-03-12 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise · Option to purchase Common Stock | −13,162 | 0 | ||
| 2018-03-09 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +6,576 | $11.83 | $78K | 6,576 |
| 2018-03-09 | Bendheim Daniel M Exec. VP, Corporate Strategy | Sale | −6,576 | $40.03 | $263K | 0 |
| 2018-03-09 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise · Option to purchase Common Stock | −6,576 | 13,162 | ||
| 2018-03-08 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +3,425 | $11.83 | $41K | 3,425 |
| 2018-03-08 | Bendheim Daniel M Exec. VP, Corporate Strategy | Sale | −3,425 | $40.00 | $137K | 0 |
| 2018-03-08 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise · Option to purchase Common Stock | −3,425 | 19,738 | ||
| 2018-03-07 | BFI Co., LLC 10% owner | Sale | −12,000 | $38.92 | $467K | 36,000 |
| 2018-03-07 | BENDHEIM JACK President and CEO | Sale | −12,000 | $38.92 | $467K | 36,000 |
| 2018-03-06 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +100 | $11.83 | $1K | 100 |
Page 20 of 41 · 803 trades